Movano

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Leabman in January 2018 and is headquartered in Pleasanton, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Movano Health reports revenue growth but faces operating loss in Q1 2024

Movano Health's Q1 2024 performance showed revenue from Evie Ring shipments but an operating loss, mitigated by a $24 million private placement. The company aims to optimize operations, secure FDA clearance, and expand partnerships to drive growth and profitability.

Movano Health advances FDA-cleared products, eyes clinical trials for growth

Movano Health's Q2 2024 earnings call highlighted progress, challenges, and opportunities in the health monitoring technology sector. With a focus on product development, marketing strategies, and capital management, Movano aims to drive growth and innovation in the market.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PLEASANTON, Calif. , June 15, 2023 /PRNewswire/ -- Movano Health  (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced the closing of its $9.2 million underwritten public offering of 9,200,000 shares of its common stock, including 1,200,000 shares of its common stock issued pursuant to the full exercise by the underwriter of its over-allotment option.

Movano Health Announces Closing of $9.2 Million Public Offering Including Full Exercise of Over-Allotment Option

PLEASANTON, Calif. , June 13, 2023 /PRNewswire/ -- Movano Health  (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced that it has priced an $8.0 million underwritten public offering of 8,000,000 shares of its common stock.

Movano Health Prices $8.0 Million Public Offering

Movano Inc. (NASDAQ:MOVE ) Q1 2023 Earnings Conference Call May 15, 2023 12:00 PM ET Company Participants J. Cogan – Chief Financial Officer John Mastrototaro – Chief Executive Officer Tyla Bucher – Chief Marketing Officer Stacy Salvi – Vice President of Strategy Michael Leabman – Founder and Chief Technology Officer Conference Call Participants Operator Greetings, and welcome to Movano's First Quarter 2023 Earnings Call.

Movano Inc. (MOVE) Q1 2023 Earnings Call Transcript

Conference call begins at 9:00 a.m. Pacific time today PLEASANTON, Calif.

Movano Health Provides Business Update and Reports First Quarter 2023 Financial Results

PLEASANTON, Calif. , April 24, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the  Evie Ring , today announced that it will report first quarter 2023 financial and operating results on Monday, May 15, 2023.

Movano Inc. to Report First Quarter 2023 Financial Results on Monday, May 15, 2023

Movano Inc. (NASDAQ:MOVE ) Q4 2022 Earnings Conference Call March 20, 2023 12:00 PM ET Company Participants J. Cogan - Chief Financial Officer John Mastrototaro - Chief Executive Officer Tyla Bucher - Chief Marketing Officer Michael Leabman - Founder and Chief Technology Officer Stacy Salvi - Vice President of Strategy Conference Call Participants Bruce Jackson - The Benchmark Company Operator Hello, and welcome to Movano Health Fourth Quarter 2022 Earnings Call.

Movano Inc. (MOVE) Q4 2022 Earnings Call Transcript

Movano Health Provides Business Update and Reports Fourth Quarter 2022 Financial Results

Company developed its proprietary radio frequency technology to improve upon accuracy, cost and the size of wearable health technology PLEASANTON, Calif. , March 14, 2023 /PRNewswire/ --  Movano Health  (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, has been granted three new patents (2 US; 1 China) further safeguarding the Company's systems and methods for radio frequency-enabled health monitoring with specific protection for health parameters of blood glucose levels, blood pressure and heart rate.

Movano Health Awarded Three New Core Patents Validating its Cutting-Edge Approach to Radio Frequency-Enabled Glucose and Blood Pressure Monitoring

Movano Health's survey of 1,000 U.S. women reveals that accuracy of data is a critical feature for those considering a wearable to help them manage health. The company is eyeing an FDA clearance submission for its Evie Ring to give consumers a higher level of trust in their health data.

What Women Want: Accuracy is Critical to Future Wearable Use

PLEASANTON, Calif. , Feb. 23, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ: MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the  Evie Ring , today announced that it will report fourth quarter 2022 financial and operating results on Monday, March 20, 2023.

Movano Inc. to Report Fourth Quarter 2022 Financial Results on Monday, March 20, 2023

PLEASANTON, Calif. , Feb. 6, 2023 /PRNewswire/ -- Movano Health  (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced that it has completed a $7.5 million underwritten public offering of 5,340,600 shares of its common stock and warrants to purchase up to 2,670,300 shares of common stock, including the full exercise of the underwriter's overallotment option.

Movano Health Completes $7.5 Million Public Offering

PLEASANTON, Calif. , Jan. 27, 2023 /PRNewswire/ -- Movano Health  (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced that it has priced a $6.5 million underwritten public offering of 4,644,000 shares of its common stock and warrants to purchase up to 2,322,000 shares of common stock.

Movano Health Prices $6.5 Million Public Offering

Movano's getting a week's jump on what might well prove a banner CES for the smart ring. Today the Bay Area-based firm debuted Evie, a smart ring focused on women's health set to hit the market later next year.

Movano's new smart ring is focused on women's health

Company plans to file for FDA clearance of a new wearable that provides women with medical grade data and personalized actionable insights to track and manage overall health PLEASANTON, Calif. , Dec. 28, 2022 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices, today announces its smart ring, Evie.

Movano Health Unveils Evie: First Medical Grade Smart Ring Designed Uniquely for Women

Preliminary results demonstrated high accuracy of SpO2  and heart rate data in its pivotal hypoxia trial, bringing the Company one step closer to developing a medical device PLEASANTON, Calif. , Dec. 14, 2022 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices, today announces successful preliminary results of its pivotal hypoxia trial, which was completed in conjunction with the University of California, San Francisco (UCSF) to assess the accuracy of its smart ring's blood oxygen saturation (SpO2) and heart rate data.

Movano Health On Track to File First FDA Submission for its Smart Ring's SpO2 and Heart Rate Data Following Successful Pivotal Hypoxia Trial

The beta program is designed to advance the development of Movano Health's comprehensive health data monitoring solution WINSTON-SALEM, N.C. and PLEASANTON, Calif.

Movano Health Announces Launch of Smart Ring Beta Program with Novant Health

PLEASANTON, Calif. , Nov. 16, 2022 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices, today announced it will be participating at several upcoming investor-focused events.

Movano Health to Participate in Bernstein CGM Disruptors Conference, BTIG Digital Health Forum and Benchmark Discovery Conference

Movano Inc. (NASDAQ:MOVE ) Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ET Company Participants J. Cogan – Chief Financial Officer John Mastrototaro – Chief Executive Officer Stacy Salvi – Vice President of Strategy Conference Call Participants Marie Thibault – BTIG Operator Greetings.

Movano Inc. (MOVE) Q3 2022 Earnings Call Transcript

Conference call begins at 2:00 p.m. Pacific time today PLEASANTON, Calif.

Movano Health Provides Business Update and Reports Third Quarter 2022 Financial Results

PLEASANTON, Calif. , Nov. 1, 2022 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, today announced that it will report third quarter 2022 financial and operating results on Monday, November 14, 2022.

Movano Inc. to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022

Movano Inc. (NASDAQ:MOVE ) Q2 2022 Earnings Conference Call August 17, 2022 5:00 PM ET Company Participants John Mastrototaro - CEO J. Cogan - CFO Michael Leabman - CTO Conference Call Participants Operator Greeting and welcome to the Movano Second Quarter 2022 Earnings Call.

Movano Inc. (MOVE) CEO John Mastrototaro on Q2 2022 Results - Earnings Call Transcript

Movano Inc. Provides Business Update and Reports Second Quarter 2022 Financial Results

PLEASANTON, Calif. , Aug. 15, 2022 /PRNewswire/ -- Movano Inc. (NASDAQ: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, today announced the development of a beta testing program with Stanford Health Applied Sports Science Department.

Movano Announces Beta Program with Stanford University to Advance the Development of Comprehensive Health Data Monitoring for its Wearable Ring Solution

Former Google FitBit and Liteboxer talent join Movano as it prepares for commercialization of the Movano Ring PLEASANTON, Calif. , Aug. 11, 2022 /PRNewswire/ -- Movano Inc. (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announces today the expansion of its go-to-market leadership team with two strategic hires: Daniel Amara is joining as Vice President of User Experience (UX) and User Interface (UI) and Jim Chambers as Vice President of Digital Marketing & Growth.

Movano Expands Go-To-Market Team with Vice President of UX and UI and Vice President of Digital Marketing and Growth

Vital health metric demonstrates wearable's potential to properly track heart health and detect possible illnesses PLEASANTON, Calif. , Aug. 9, 2022 /PRNewswire/ -- Movano Inc.  (NASDAQ: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announces today the successful completion of a study with the University of California San Francisco (UCSF) to assess the accuracy of the Movano Ring's blood oxygen saturation (SpO2) and heart rate data.

News for Movano Stock (MOVE)